Suresh Acharya, Professor of Practice at the University of Maryland’s Robert H. Smith School of Business, lays out the challenges of creating an end-to-end supply chain that can produce and distribute millions of doses of a vaccine for COVID-19.
Here’s a breakdown of how a Biden presidency may affect some two dozen U.S. industries and what might rise to the top of his agenda as he takes over from Donald Trump in January.
The coronavirus pandemic has led to severe shortages of personal protective equipment (PPE) needed to protect Americans from the disease. The crisis has revealed an overreliance on imported supplies, particularly from China.
Robert Eubanks, director of healthcare and life sciences with West Monroe, discuses the changes in how vaccines and drug therapies are developed and distributed as a result of the COVID-19 pandemic.
The medical industry’s dash to produce the world’s first coronavirus vaccines in just a few months is heightening the urgency for the workhorses of global trade to be ready for the historic charge to defeat the disease.
The latest supply-chain news, analysis, trends and tools for executives in the healthcare industry. Learn how healthcare companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.